Study interventions
The present study was conducted on 34 patients suffering from symptomatic OLP. Patients were randomly divided into two groups and received both treatments in the form of opaque sealed jars (Jar A) for adhesive tablets (Fig. Opaque sealed jar containing mucoadhesive CoQ10 tablets